TopiVert Revenue and Competitors

Stevenage,

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • TopiVert's estimated annual revenue is currently $7.8M per year.(i)
  • TopiVert's estimated revenue per employee is $201,000

Employee Data

  • TopiVert has 39 Employees.(i)
  • TopiVert grew their employee count by 11% last year.

TopiVert's People

NameTitleEmail/Phone
1
CTO, Autifony TherapeuticsReveal Email/Phone
2
Head Biology at Autifony TherapeuticsReveal Email/Phone
3
Head Clinical Project ManagementReveal Email/Phone
4
Junior Medicinal ChemistReveal Email/Phone
5
Junior Medicinal ChemistReveal Email/Phone
6
Junior electrophysiologistReveal Email/Phone
7
Molecular BiologistReveal Email/Phone
8
Chimico MedicinaleReveal Email/Phone
9
ElectrophysiologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$46.2M2305%N/AN/A
#2
$43.8M21821%N/AN/A
#3
$57.1M28426%N/AN/A
#4
$24.5M1223%N/AN/A
#5
$52.9M26313%N/AN/A
#6
$24.7M12313%N/AN/A
#7
$1.8M180%$114.3MN/A
#8
$7.2M36-20%N/AN/A
#9
$13.7M68-7%N/AN/A
#10
$7.6M39-13%$123.9MN/A
Add Company

What Is TopiVert?

Autifony Therapeutics Limited is a UK-based company that specialises in researching treatments for hearing disorders, tinnitus, age related hearing loss and schizophrenia. The company's main focus is the discovery and development of new pharmaceutical treatments for hearing disorders, such as age related hearing loss, and for other serious central nervous system disorders such as schizophrenia.

keywords:N/A

N/A

Total Funding

39

Number of Employees

$7.8M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

TopiVert News

2022-04-19 - Global Tyrosine Protein Kinase SYK Market To Witness Huge ...

... Merck KGaA, Millennium Pharmaceuticals Inc, Portola Pharmaceuticals Inc, Rigel Pharmaceuticals Inc, TopiVert Ltd, key market vendors,...

2022-03-30 - Difficult-to-treat inflammatory bowel disease: results from a ...

... Protagonist Therapeutics, Reistone Biopharma, Roche, Sandoz, Second Genome, Takeda, Teva Pharmaceuticals, Topivert Pharma, and Vividion Therapeutics;...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.5M47N/AN/A
#2
$14.3M57-7%N/A
#3
$15.5M60-3%N/A
#4
$14.1M71-9%N/A
#5
N/A767%N/A